Device to treat aberrant neural reflex arcs in peripheral and visceral disease

Tulavi Therapeutics focuses on advancing peripheral nerve surgery through its innovative Adaptive Hydrogel Technology. This technology is specifically designed to enhance nerve healing and improve outcomes in neuroma prevention, adhesion reduction, and nerve repair. The allay™ Nerve Cap, a key product of Tulavi, utilizes a fully absorbable, in situ forming hydrogel that optimizes recovery by aligning its absorption rate with the healing profile of the treated nerve. This unique design not only provides a protective layer that accommodates post-operative swelling but also reduces friction, facilitating tissue gliding and supporting mobilization after surgery.

The Adaptive Hydrogel Technology also features strong mechanical adherence to the nerve, which helps to block axonal escape and minimizes the risk of neuroma formation. Additionally, it allows for the exchange of nutrients and oxygen while inhibiting unwanted cell migration, thereby promoting effective healing. Tulavi's mission is to deliver consistent results in nerve care, addressing the challenges posed by current treatment methods and ensuring broader access to effective nerve care solutions.

United States

Tulavi Therapeutics is a privately held company, developing a portfolio of innovative nerve repair products. Tulavi's innovative Adaptive Hydrogel Technology is engineered to support nerve healing and address the poor and unpredictable outcomes in neuroma prevention, adhesion reduction, and nerve repair.

Tulavi

Company Details